The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
Registration is open for the global event that invites technology enthusiasts to bring innovative ideas to improve healthcare outcomes
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices
Organizations to combine expertise to further develop AI/ML-powered drug design platform, delivering precise, effective, and life-changing medicines at scale
Building the future of food in the birthplace of cell-cultured milk
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
Enables millions of Indians to monitor their vitals without the need of any additional device
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
Machine learning approach to systems biology combined with ligand discovery platform
Subscribe To Our Newsletter & Stay Updated
